1
Enquiry period
with 02.05.2023 15:52
to 04.05.2023 12:00
2
Bidding period
with 04.05.2023 12:00
to 11.05.2023 12:00
3
Auction
12.05.2023 11:18
4
Evaluation
5
Bids have been evaluated
Status Active
Estimated value without VAT 1 700 MDL
Period of clarifications: 2 May 2023, 15:52 - 4 May 2023, 12:00
Submission of proposals: 4 May 2023, 12:00 - 11 May 2023, 12:00
Auction start date: 12 May 2023, 11:18

Supplier technical support:

(+373) 79999801

Ser anti – P1
Information about customer
Fiscal code/IDNO
Address
MD-2025, MOLDOVA, mun.Chişinău, mun.Chişinău, Vl.Korolenko,8
Web site
---
The contact person
Full name
Furdui Doina
Contact phone
022 73 87 33 / 067 744 986
Purchase data
Date created
2 May 2023, 15:37
Date modified
2 May 2023, 15:52
Estimated value (without VAT)
1 700 MDL
The minimum downward of the price
17 MDL
Achizitii.md ID
21079651
Type of procedure
Low cost purchase
Award criteria
The lowest price
Delivery address
MD-2025, MOLDOVA, mun.Chişinău, mun.Chişinău, Vl.Korolenko,8
Contract period
13 May 2023 15:39 - 31 Dec 2023 15:51
List of positions
1)
Title
Ser anti – P1 CPV: 33600000-6 - Pharmaceutical products
Quantity: 5.0
Unit of measurement: Centimetru cub; mililitru
Documents of the procurement procedure
Lot documents

The offers of the participants are available below, you can view the documents for the offers by clicking on the folder icon.

Based on the Working Group Decision, the selection of a winner requires:

1) Disqualify participants whose price is lower than that of the winner and indicate the reason for the disqualification.

2) Choose winner by clicking the button

4) After choosing the winner, press the button: "Confirm"..

Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

GBG-MLD SRL

Normalized price: 1 700 MDL
Status: In consideration
Reason: Not indicated
Qualification documents
Documents folder missing
Documents provided with the proposal
The history of the auction
View auction
Unfortunately, questions can be asked only during the "Active" period.
Clarifications